The legacy of Viagra, and its creator copyright, presents a intriguing case study for investors. Originally a blockbuster drug, generating billions in income, its intellectual property lapse created a wave of lower-priced alternatives , significantly diminishing its position . While specific firms may attempt to capitalize on similar conditions , t